College Factual  by our College Data Analytics Team
       Unbiased Factual Guarantee

University of Washington - Seattle Campus Master’s in Clinical and Industrial Drug Development

14 Master's Degrees Awarded

Clinical and Industrial Drug Development is a concentration offered under the pharmacy/pharmaceutical sciences major at University of Washington - Seattle Campus. We’ve gathered data and other essential information about the master’s degree program in clinical and industrial drug development, such as if the program is offered online, ethnicity of students, how many students graduated in recent times, and more.

If there’s something special you’re looking for, you can use one of the links below to find it:

How Much Does a Master’s in Clinical and Industrial Drug Development from UW Seattle Cost?

$17,394 Average Tuition and Fees

UW Seattle Graduate Tuition and Fees

Out-of-state part-time graduates at UW Seattle paid an average of $1,389 per credit hour in 2019-2020. The average for in-state students was $775 per credit hour. Information about average full-time graduate student tuition and fees is shown in the table below.

In State Out of State
Tuition $16,278 $29,178
Fees $1,116 $1,116

Does UW Seattle Offer an Online Master’s in Clinical and Industrial Drug Development?

UW Seattle does not offer an online option for its clinical and industrial drug development master’s degree program at this time. To see if the school offers distance learning options in other areas, visit the UW Seattle Online Learning page.

UW Seattle Master’s Student Diversity for Clinical and Industrial Drug Development

14 Master's Degrees Awarded
64.3% Women
35.7% Racial-Ethnic Minorities*
In the 2019-2020 academic year, 14 students received their master’s degree in clinical and industrial drug development. The gender and racial-ethnic breakdown of those individuals is shown below.

Male-to-Female Ratio

Women made up around 64.3% of the clinical and industrial drug development students who took home a master’s degree in 2019-2020. This is less than the nationwide number of 71.4%.

undefined

Racial-Ethnic Diversity

Around 35.7% of clinical and industrial drug development master’s degree recipients at UW Seattle in 2019-2020 were awarded to racial-ethnic minorities*. This is higher than the nationwide number of 29%.

undefined
Race/Ethnicity Number of Students
Asian 3
Black or African American 0
Hispanic or Latino 1
Native American or Alaska Native 0
Native Hawaiian or Pacific Islander 0
White 3
International Students 6
Other Races/Ethnicities 1

You may also be interested in one of these majors related to clinical and industrial drug development.

Related Major Annual Graduates
Pharmaceutics and Drug Design 13
Pharmacoeconomics/Pharmaceutical Economics 9

View All Clinical and Industrial Drug Development Related Majors >

References

*The racial-ethnic minorities count is calculated by taking the total number of students and subtracting white students, international students, and students whose race/ethnicity was unknown. This number is then divided by the total number of students at the school to obtain the racial-ethnic minorities percentage.

More about our data sources and methodologies.

Popular Reports

College Rankings
Best by Location
Degree Guides by Major
Graduate Programs

Compare Your School Options